Back to Search

Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma


  • Protocol Number: 202003124
  • Principal Investigator: Ansstas, George
  • Cancer Types: Melanoma & Skin

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions